Sarah Watson
- Surgery top 10%
- Toxicology top 0.5%
- Cardiology and Cardiovascular Medicine
- Molecular Biology
- Epidemiology
- Co-authors
- Ola CasterHester M. den RuijterPaula A. RochonAlbert HofmanChristie M. BallantyneEmanuele Di AngelantonioChris J. PackardStephen Kaptoge
- Topics
- Pharmacovigilance and Adverse Drug Reactions (9 papers)Drug-Induced Adverse Reactions (3 papers)Pharmaceutical Economics and Policy (3 papers)
- Partner nations
- SwedenUnited KingdomNetherlands
In The Last Decade
Sarah Watson
14 papers receiving 844 citations
Peers
Comparison fields: 5 of 107
- Surgery 286
- Toxicology 208
- Cardiology and Cardiovascular Medicine 131
- Molecular Biology 129
- Epidemiology 128
Countries citing papers authored by Sarah Watson
This map shows the geographic impact of Sarah Watson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Watson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Watson more than expected).
Fields of papers citing papers by Sarah Watson
This network shows the impact of papers produced by Sarah Watson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Watson. The network helps show where Sarah Watson may publish in the future.
Co-authorship network of co-authors of Sarah Watson
This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Watson. A scholar is included among the top collaborators of Sarah Watson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Watson. Sarah Watson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 15 | |
| 2 | 5 | |
| 3 | 4 | |
| 4 | 6 | |
| 5 | 0 | |
| 6 | 0 | |
| 7 | 0 | |
| 8 | 1 | |
| 9 | 24 | |
| 10 | 161 | |
| 11 | 6 | |
| 12 | 36 | |
| 13 | 24 | |
| 14 | 12 | |
| 15 | A Paradigm Shift for Screening Individual Case Reports : Accounting for Quality and Content | 1 |
| 16 | 82 | |
| 17 | 481 | |
| 18 | 10 |
About Sarah Watson
Sarah Watson is a scholar working on Toxicology, Hepatology and Developmental Neuroscience, having authored 18 papers that have together received 868 indexed citations. Recurring topics across this work include Pharmacovigilance and Adverse Drug Reactions (9 papers), Drug-Induced Adverse Reactions (3 papers) and Pharmaceutical Economics and Policy (3 papers). The work is most often cited by research in Toxicology (208 citations), Geriatrics and Gerontology (35 citations) and Cancer Research (118 citations). Sarah Watson has collaborated with scholars based in Sweden, United Kingdom and Netherlands. Frequent co-authors include Ola Caster, Hester M. den Ruijter, Paula A. Rochon, Albert Hofman, Christie M. Ballantyne, Emanuele Di Angelantonio, Chris J. Packard, Stephen Kaptoge, Alexander Thompson and Rory Collins. Their work appears in journals such as The Lancet, Geophysical Journal International and British Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.